Children's Hospital of Michigan
Linezolid effective against nosocomial VREF in premature infant
Published in Patient Care Law Weekly, May 2nd, 2004
According to a study from the United States, a "4 1/2-month-old, 26-week premature infant with multiple complications of prematurity required a central venous catheter for venous access and antibiotic treatment of bacterial nosocomial infections.
"He developed tricuspid valve endocarditis with vegetation caused by Enterococcus faecium resistant to ampicillin, vancomycin and quinupristin-dalfopristin but susceptible to linezolid," reported J.Y. Ang and coauthors at the Children's Hospital of Michigan.
"He was successfully treated with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
More Articles from Patient Care Law Weekly
- Abortion
Doctor testifies that banned type of abortion needs more study - Adoption Issues
Oklahoma health department to issue birth certificates to same-sex couples - Alza Corp.
Mylan loses patent infringement suit - Barr Laboratories, Inc.
Kos files suit for infringement of new Niaspan patent - Breast Cancer
Exposure to famine associated with increased cancer risk - Ciphergen Biosystems, Inc.
Data on disease-specific inflammatory diagnostics reported at cancer meeting - More from this issue of Patient Care Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
